Irene Gottlob Selected Research

Multiple Sclerosis

11/2002

Combined pharmacologic and surgical approach to acquired nystagmus due to multiple sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Irene Gottlob Research Topics

Disease

13	Albinism 04/2024 - 08/2011
9	Color Vision Defects (Color Blindness) 01/2022 - 05/2011
5	Amblyopia (Lazy Eye) 06/2019 - 04/2005
3	X-Linked Infantile Nystagmus 02/2014 - 01/2010
2	Retinopathy of Prematurity (Retrolental Fibroplasia) 10/2023 - 08/2020
2	congenital fibrosis of the extraocular muscles 03/2021 - 12/2003
2	Esotropia (Esophoria) 01/2020 - 01/2018
2	Glaucoma 01/2020 - 01/2019
2	Refractive Errors (Refractive Error) 12/2016 - 01/2016
2	Optic Nerve Diseases (Optic Neuropathy) 01/2016 - 02/2014
2	Pathologic Nystagmus 03/2009 - 11/2002
2	Strabismus (Squint) 10/2006 - 12/2003
1	Macular Edema 10/2023
1	Ganglion Cysts (Ganglion) 01/2023
1	Photophobia (Light Sensitivity) 01/2023
1	Inflammation (Inflammations) 01/2023
1	Atrophy 01/2021
1	Blindness (Hysterical Blindness) 01/2021
1	Cysts 01/2021
1	Cognitive Dysfunction 01/2021
1	Schizophrenia (Dementia Praecox) 01/2018
1	Microcephaly 01/2018
1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 01/2017
1	Optic Nerve Hypoplasia 03/2014
1	Diabetic Retinopathy (Retinopathy, Diabetic) 02/2014
1	Papilledema 02/2014
1	Neuroblastoma 01/2010
1	Nervous System Diseases (Neurological Disorders) 01/2010
1	Weight Gain 02/2008
1	Trochlear Nerve Diseases (Fourth Nerve Palsy) 02/2008
1	Amyloidosis 07/2007
1	Congenital Nystagmus 02/2007
1	autosomal recessive Spastic paraplegia 15 10/2005
1	3B Congenital Fibrosis of Extraocular Muscles 12/2003
1	Disease Progression 12/2002
1	Multiple Sclerosis 11/2002

Drug/Important Bio-Agent (IBA)

30	Retinaldehyde (Retinal)IBA 10/2023 - 10/2005
5	Proteins (Proteins, Gene)FDA Link 01/2020 - 12/2003
3	Memantine (Namenda)FDA Link 03/2009 - 02/2007
3	Gabapentin (Neurontin)FDA LinkGeneric 02/2008 - 11/2002
2	poly(dG-dA)n.poly(dC-dT)n (((GA)n))IBA 10/2023 - 08/2020
1	N 30IBA 02/2024
1	SteroidsIBA 01/2023
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Long Noncoding RNAIBA 01/2020
1	Atropine FDA LinkGeneric 06/2019
1	Tryptophan (L-Tryptophan)FDA Link 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Melanins (Melanin)IBA 01/2017
1	Protein Isoforms (Isoforms)IBA 04/2016
1	Cholinergic ReceptorsIBA 04/2016
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 04/2016
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 04/2016
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2010
1	TubulinIBA 01/2010
1	Amyloid (Amyloid Fibrils)IBA 07/2007
1	Mydriatics (Cycloplegics)IBA 10/2006
1	KinesinsIBA 12/2003
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2002

Therapy/Procedure

3	Telescopes 06/2019 - 12/2003
3	Therapeutics 06/2019 - 04/2005
1	Electrodes (Electrode) 04/2024
1	Aftercare (After-Treatment) 10/2006